Research Advisory Council (RAC)


PCC is advised and counseled by a Research Advisory Council (RAC) that comprises prominent prostate cancer researchers. The role of RAC is to:
  • Synthesize the results of the peer review process and make recommendations for funding to senior PCC staff
  • Receive reports of the evaluation of PCC research programs and provide advice on the development of new programs and the ongoing improvements to existing programs
  • Lead the identification of strategic research areas that could be targeted with specific Requests For Applications
  • Evaluate the PCC peer review processes and recommend necessary enhancements on an ongoing basis
  • Recommend membership of peer review panels
  • Identify potential national and international opportunities for collaboration
  • Provide advice in the development and refinements of scientific and administrative policies
The Council will be composed of established prostate cancer researchers who:
  • Collectively represent expertise in all areas of prostate cancer research
  • Are broadly representative of all major regions in Canada
  • Individually have a strong track record in peer-reviewed research funding and research output
In addition, the Council will include 2 non-scientific members, one of whom must be a prostate cancer patient or survivor. Each will be identified and selected through a formal nomination process.

Current Membership

David Berman, Queen's Cancer Research Institute, Kingston, ON
Paul Boutros, Ontario Institute for Cancer Research (OICR), Toronto
, ON
Ralph Buttyan, Vancouver Prostate Centre, Vancouver, BC
Kim Chi, BC Cancer Agency, Vancouver, BC
Michael Cox, University of British Columbia, Vancouver, BC

Stuart Edmonds (Ex Officio), Prostate Cancer Canada, Toronto, ON
Carolyn Gotay, University of British Columbia, Vancouver, BC
Masoom Haider, Sunnybrook Research Institute, Toronto
, ON
Winston Klass, Community Representative, Concord, ON
John Lewis, University of Alberta, Edmonton, AB
Randy Mellow, Community Representative, Peterborough, ON

Ian G.Mills, Queen's University Belfast, Belfast, UK
John Oliffe, University of British Columbia, Vancouver
, BC
Marie-Elise Parent, INRS–Institut Armand-Frappier Research Centre, Laval, QC
Fred Saad, Université de Montréal, Montreal, QC
Gurmit Singh (Scientific Chair), McMaster University, Hamilton, ON

John Valliant, McMaster University, Hamilton, ON
Danny Vesprini, Sunnybrook Research Institute, Toronto, ON

As of June 26, 2017





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More

Plaid for Dad participation skyrockets in third year

July 7, 2017 - TORONTO, ON - Launched for the first time in 2015, Prostate Cancer Canada's (PCC) Plaid for Dad campaign has further established itself as the way Canadians are choosing to give back on Father's Day weekend.
More


Click here for news archive